Pawan Kumar Raghav

663 total citations
22 papers, 399 citations indexed

About

Pawan Kumar Raghav is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Pawan Kumar Raghav has authored 22 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Pawan Kumar Raghav's work include Cell death mechanisms and regulation (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Computational Drug Discovery Methods (3 papers). Pawan Kumar Raghav is often cited by papers focused on Cell death mechanisms and regulation (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Computational Drug Discovery Methods (3 papers). Pawan Kumar Raghav collaborates with scholars based in India, United States and United Kingdom. Pawan Kumar Raghav's co-authors include Sujata Mohanty, Gurudutta Gangenahalli, Yogesh Kumar Verma, Ajay Singh, Gajendra P. S. Raghava, Vinod Kumar, Rajesh Kumar, Raja Rajalingam, Yogesh Kumar Verma and Dinesh Kumar and has published in prestigious journals such as PLoS ONE, Scientific Reports and Life Sciences.

In The Last Decade

Pawan Kumar Raghav

21 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pawan Kumar Raghav India 13 178 67 63 55 53 22 399
Sedigheh Sharifzadeh Iran 11 130 0.7× 42 0.6× 30 0.5× 49 0.9× 41 0.8× 49 360
David Knoff United States 10 170 1.0× 91 1.4× 74 1.2× 35 0.6× 122 2.3× 14 418
Daniel P. Feldmann United States 8 224 1.3× 81 1.2× 48 0.8× 26 0.5× 22 0.4× 10 418
Huo Tan China 13 216 1.2× 115 1.7× 43 0.7× 122 2.2× 38 0.7× 43 472
Byung‐Chul Lee South Korea 14 346 1.9× 59 0.9× 80 1.3× 35 0.6× 40 0.8× 29 552
Qiming Chen China 10 192 1.1× 80 1.2× 73 1.2× 82 1.5× 37 0.7× 31 436
Katie M. Kuo United States 11 162 0.9× 53 0.8× 36 0.6× 50 0.9× 33 0.6× 16 342
Edina Gyukity-Sebestyén Hungary 10 216 1.2× 22 0.3× 55 0.9× 122 2.2× 43 0.8× 14 376
Ilja Ritamo Finland 13 463 2.6× 53 0.8× 39 0.6× 48 0.9× 139 2.6× 15 613

Countries citing papers authored by Pawan Kumar Raghav

Since Specialization
Citations

This map shows the geographic impact of Pawan Kumar Raghav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pawan Kumar Raghav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pawan Kumar Raghav more than expected).

Fields of papers citing papers by Pawan Kumar Raghav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pawan Kumar Raghav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pawan Kumar Raghav. The network helps show where Pawan Kumar Raghav may publish in the future.

Co-authorship network of co-authors of Pawan Kumar Raghav

This figure shows the co-authorship network connecting the top 25 collaborators of Pawan Kumar Raghav. A scholar is included among the top collaborators of Pawan Kumar Raghav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pawan Kumar Raghav. Pawan Kumar Raghav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raghav, Pawan Kumar, et al.. (2025). Unlocking hematopoietic stem cell potential: integrative computational approaches for genomic and transcriptomic analysis. Frontiers in Cell and Developmental Biology. 13. 1589823–1589823.
2.
Raghav, Pawan Kumar, et al.. (2023). Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations. Scientific Reports. 13(1). 2351–2351. 6 indexed citations
3.
Raghav, Pawan Kumar, et al.. (2023). Potential treatments of COVID-19: Drug repurposing and therapeutic interventions. Journal of Pharmacological Sciences. 152(1). 1–21. 10 indexed citations
4.
Verma, Yogesh Kumar, et al.. (2022). Hematopoietic Stem Cell Factors: Their Functional Role in Self-Renewal and Clinical Aspects. Frontiers in Cell and Developmental Biology. 10. 664261–664261. 34 indexed citations
5.
Rawat, Sonali, Krishan Gopal Jain, Deepika Gupta, et al.. (2021). Graphene Nanofiber Composites for Enhanced Neuronal Differentiation of Human Mesenchymal Stem Cells. Nanomedicine. 16(22). 1963–1982. 12 indexed citations
6.
Raghav, Pawan Kumar, et al.. (2021). Cancer stem cells targets and combined therapies to prevent cancer recurrence. Life Sciences. 277. 119465–119465. 30 indexed citations
7.
Raghav, Pawan Kumar, et al.. (2021). Human cell receptors: potential drug targets to combat COVID-19. Amino Acids. 53(6). 813–842. 15 indexed citations
8.
Raghav, Pawan Kumar, et al.. (2021). Mesenchymal stem cell-based nanoparticles and scaffolds in regenerative medicine. European Journal of Pharmacology. 918. 174657–174657. 60 indexed citations
9.
Raghav, Pawan Kumar & Gurudutta Gangenahalli. (2021). PU.1 Mimic Synthetic Peptides Selectively Bind with GATA-1 and Allow c-Jun PU.1 Binding to Enhance Myelopoiesis. International Journal of Nanomedicine. Volume 16. 3833–3859. 4 indexed citations
10.
Kumar, Rajesh, et al.. (2020). CancerEnD: A database of cancer associated enhancers. Genomics. 112(5). 3696–3702. 16 indexed citations
11.
Raghav, Pawan Kumar & Sujata Mohanty. (2020). Are graphene and graphene-derived products capable of preventing COVID-19 infection?. Medical Hypotheses. 144. 110031–110031. 58 indexed citations
12.
Raghav, Pawan Kumar, Ajay Singh, & Gurudutta Gangenahalli. (2018). Stem cell factor and NSC87877 combine to enhance c-Kit mediated proliferation of human megakaryoblastic cells. PLoS ONE. 13(11). e0206364–e0206364. 12 indexed citations
13.
Raghav, Pawan Kumar, Ajay Singh, & Gurudutta Gangenahalli. (2018). Stem cell factor and NSC87877 synergism enhances c-Kit mediated proliferation of human erythroid cells. Life Sciences. 214. 84–97. 12 indexed citations
14.
Raghav, Pawan Kumar, Ajay Singh, & Gurudutta Gangenahalli. (2018). A change in structural integrity of c-Kit mutant D816V causes constitutive signaling. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 808. 28–38. 15 indexed citations
15.
Raghav, Pawan Kumar & Gurudutta Gangenahalli. (2018). Hematopoietic Stem Cell Molecular Targets and Factors Essential for Hematopoiesis. Journal of Stem Cell Research & Therapy. 8(11). 10 indexed citations
16.
Agrawal, Piyush, Sumeet Patiyal, Rajesh Kumar, et al.. (2018). ccPDB 2.0: an updated version of datasets created and compiled from Protein Data Bank. Database. 2019. 8 indexed citations
17.
Agrawal, Piyush, Pawan Kumar Raghav, Sherry Bhalla, Neelam Sharma, & Gajendra P. S. Raghava. (2018). Overview of Free Software Developed for Designing Drugs Based on Protein-Small Molecules Interaction. Current Topics in Medicinal Chemistry. 18(13). 1146–1167. 5 indexed citations
18.
Verma, Yogesh Kumar, Pawan Kumar Raghav, Hanumantharao G. Raj, Rajendra Prasad Tripathi, & Gurudutta Gangenahalli. (2012). Enhanced heterodimerization of Bax by Bcl-2 mutants improves irradiated cell survival. APOPTOSIS. 18(2). 212–225. 16 indexed citations
19.
Raghav, Pawan Kumar, Yogesh Kumar Verma, & Gurudutta Gangenahalli. (2011). Molecular dynamics simulations of the Bcl-2 protein to predict the structure of its unordered flexible loop domain. Journal of Molecular Modeling. 18(5). 1885–1906. 29 indexed citations
20.
Raghav, Pawan Kumar, Yogesh Kumar Verma, & Gurudutta Gangenahalli. (2011). Peptide screening to knockdown Bcl-2's anti-apoptotic activity: Implications in cancer treatment. International Journal of Biological Macromolecules. 50(3). 796–814. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sedigheh Sharifzadeh Breakdown of academic impact, for papers by David Knoff Breakdown of academic impact, for papers by Daniel P. Feldmann Breakdown of academic impact, for papers by Huo Tan Breakdown of academic impact, for papers by Byung‐Chul Lee Breakdown of academic impact, for papers by Qiming Chen Breakdown of academic impact, for papers by Katie M. Kuo Breakdown of academic impact, for papers by Edina Gyukity-Sebestyén Breakdown of academic impact, for papers by Ilja Ritamo
Rankless by CCL
2026